Bodycad received product notification confirmation which enables them to commercially launch their Unicompartmental Knee System within the European Union.
Anika Therapeutics enrolled the first patient in a supplemental Phase III trial evaluating CINGAL® viscosupplement for the treatment of knee OA symptoms.